• Updates on Cleantech and Nanotech Venture Capital
  • August 13, 2012 | Author: J. Steven Rutt
  • Law Firm: Foley & Lardner LLP - Washington Office
  • The National Venture Capital Association (NVCA) is participating in a statement responsive to the “No More Solyndras Act.”  The gist is to not “throw the baby out with the bathwater” in “fixing” the government programs that led to the Solyndra problems.

    NVCA also reports life sciences investing (biotech and medical devices) was down in Q2, the fourth quarter in a row for decline (see press release on home page for nvca re Q2).

    In comparison with life sciences, cleantech was modestly up and featured some of the largest deals in Q2, falling within the “Industrial/Energy” group, including investment deals with Fisker Automotive, Bloom Energy, Harvest Power, and SunRun, Inc. Clean technology is said to cross industries – remains a bit of a mystery what is an industry versus a sector – distinction without difference? Many technologies cross industries. Just explain why a particular classification system is chosen. For many years, it has been said that ”nanotechnology is not an industry,” but I am not sure what is the point of saying that as many things seem to not be industries (e.g., cleantech)?  Have not heard a good explanation despite asking a number of persons who make the point.

    Also, good to see the Wall Street Journal provide a nanotechnology commercialization story recently. A nanotechnology renaissance could be, indeed, a boom to the economy if the government and venture capitalists can figure out a better model for investing in the physical sciences.